Laddar populära aktier...
Redeye comments on the start of a new phase I study of mitazalimab in local pancreatic cancer.
Tessin är en digital investeringsplattform för säkerställda fastighetslån.
Redeye comments on the collaboration with University of Washington.
Under det första kvartalet år 2024 uppgick nettoomsättningen till 157,6 MSEK (148,4), motsvarande en...
Starbreeze's revenues exceeded our expectations for the quarter by 53%.
Redeye gives its initial comments on the Q1 2024 report from Precise Biometrics, which came in above...
Redeye concludes that Q1 came in below its topline expectations, but in line on EBITDA-CAPEX (underl...
Redeye provides its initial take on Acarix's Q1 report.
Q1 adj. EBIT of GBP 34m, above ABGSCe at GBP 20m Record high AUM, Valkyrie integrated Strong Q1, sto...
Sales in line with expectations EBIT (loss) 10% better Estimates likley to be revised up 3-5% on EBI...
First IPU design win with Tier 1 server OEM We lift '26e EBIT by 111% New guidance implies P/E of 3.
Earlier-than-expected cost synergies led to 4% EBITA beat We lift '24e-'26e EBITA by 3-4% on lower o...
Market activity remains muted EBIT estimates cut by 3% for 2025e-26e 2024e EV/EBIT of
In its Q124 report, IRLAB recapped its efforts in targeting major aspects of Parkinson’s disease (PD...
Redeye raises its Base Case and forecasts following a strong Q1 report, with the strong gross margin...